Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.

Smith CL, Chaichana KL, Lee YM, Lin B, Stanko KM, O'Donnell T, Gupta S, Shah SR, Wang J, Wijesekera O, Delannoy M, Levchenko A, Quiñones-Hinojosa A.

Stem Cells Transl Med. 2015 Mar;4(3):239-51. doi: 10.5966/sctm.2014-0149. Epub 2015 Feb 2.

2.

Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas.

Pendleton C, Li Q, Chesler DA, Yuan K, Guerrero-Cazares H, Quinones-Hinojosa A.

PLoS One. 2013;8(3):e58198. doi: 10.1371/journal.pone.0058198. Epub 2013 Mar 12.

3.

Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival.

Li Q, Wijesekera O, Salas SJ, Wang JY, Zhu M, Aprhys C, Chaichana KL, Chesler DA, Zhang H, Smith CL, Guerrero-Cazares H, Levchenko A, Quinones-Hinojosa A.

Clin Cancer Res. 2014 May 1;20(9):2375-87. doi: 10.1158/1078-0432.CCR-13-1415.

4.

In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.

Cao M, Mao J, Duan X, Lu L, Zhang F, Lin B, Chen M, Zheng C, Zhang X, Shen J.

Int J Cancer. 2018 Mar 1;142(5):1033-1046. doi: 10.1002/ijc.31113. Epub 2017 Oct 31.

5.

Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.

Behnan J, Isakson P, Joel M, Cilio C, Langmoen IA, Vik-Mo EO, Badn W.

Stem Cells. 2014 May;32(5):1110-23. doi: 10.1002/stem.1614.

6.

Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

Mangraviti A, Tzeng SY, Gullotti D, Kozielski KL, Kim JE, Seng M, Abbadi S, Schiapparelli P, Sarabia-Estrada R, Vescovi A, Brem H, Olivi A, Tyler B, Green JJ, Quinones-Hinojosa A.

Biomaterials. 2016 Sep;100:53-66. doi: 10.1016/j.biomaterials.2016.05.025. Epub 2016 May 21.

7.

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines.

Birnbaum T, Roider J, Schankin CJ, Padovan CS, Schichor C, Goldbrunner R, Straube A.

J Neurooncol. 2007 Jul;83(3):241-7. Epub 2007 Feb 14.

PMID:
17570034
8.

Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218.

Kim R, Park SI, Lee CY, Lee J, Kim P, Oh S, Lee H, Lee MY, Kim J, Chung YA, Hwang KC, Maeng LS, Chang W.

Mol Cell Biochem. 2017 Mar;427(1-2):177-185. doi: 10.1007/s11010-016-2909-5. Epub 2016 Dec 30.

9.

Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.

Kosaka H, Ichikawa T, Kurozumi K, Kambara H, Inoue S, Maruo T, Nakamura K, Hamada H, Date I.

Cancer Gene Ther. 2012 Aug;19(8):572-8. doi: 10.1038/cgt.2012.35. Epub 2012 Jun 29.

10.

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.

Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS.

Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451.

11.

The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme.

Velpula KK, Dasari VR, Rao JS.

Cell Cycle. 2012 Jun 15;11(12):2303-13. doi: 10.4161/cc.20766. Epub 2012 Jun 15.

12.

Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis.

Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, Lam PY.

Stem Cells. 2013 Jan;31(1):146-55. doi: 10.1002/stem.1247.

13.

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.

Gomes ED, Vieira de Castro J, Costa BM, Salgado AJ.

Biochimie. 2018 Dec;155:59-66. doi: 10.1016/j.biochi.2018.07.008. Epub 2018 Jul 19. Review.

PMID:
30031037
14.

Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.

Parker Kerrigan BC, Shimizu Y, Andreeff M, Lang FF.

Cytotherapy. 2017 Apr;19(4):445-457. doi: 10.1016/j.jcyt.2017.02.002. Epub 2017 Feb 21. Review.

15.

ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts.

Wildburger NC, Wood PL, Gumin J, Lichti CF, Emmett MR, Lang FF, Nilsson CL.

J Proteome Res. 2015 Jun 5;14(6):2511-9. doi: 10.1021/acs.jproteome.5b00076. Epub 2015 Apr 29.

16.

In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution.

Kim SM, Jeong CH, Woo JS, Ryu CH, Lee JH, Jeun SS.

Int J Nanomedicine. 2015 Dec 18;11:13-23. doi: 10.2147/IJN.S97073. eCollection 2016.

17.

Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.

Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM, Lee MJ, Jang IH, Kwon SM, Lee JS, Kim JH.

Biochim Biophys Acta. 2013 Dec;1832(12):2136-44. doi: 10.1016/j.bbadis.2013.08.002. Epub 2013 Aug 16.

18.

Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.

Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN, Qiao W, Zhang W, Lang FF.

Neoplasia. 2011 Aug;13(8):716-25.

19.

Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.

Balyasnikova IV, Prasol MS, Ferguson SD, Han Y, Ahmed AU, Gutova M, Tobias AL, Mustafi D, Rincón E, Zhang L, Aboody KS, Lesniak MS.

Mol Ther. 2014 Jan;22(1):140-8. doi: 10.1038/mt.2013.199. Epub 2013 Sep 3.

20.

Supplemental Content

Support Center